相关实验视频

Updated: Feb 19, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

克服CXCR4介导的T细胞排斥有助于抗瘤细胞毒性在纤维状瘤癌中

Jason A Carter¹, Lindsay K Dickerson¹, Andreas Stephanou²

¹Department of Surgery, University of Washington, Seattle, Washington.

Gastroenterology

|February 17, 2026

概括

纤维状瘤 (FLC) 耐治疗性是由于T细胞排斥和耗尽. 针对CXCR4和PD-1的组合疗法克服了这些障碍,在临床前模型中增加了瘤细胞死亡.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

纤维状瘤 (FLC) 是年轻成年人罕见的一种肝癌.
FLC患者具有瘤性融合基因,但表现出有限的抗瘤免疫力和免疫治疗反应.
假设:T细胞排斥和内免疫抑制限制了FLC中的免疫治疗疗效.

研究的目的:

在FLC中调查瘤免疫微环境 (TIME).
确定免疫疗法耐药性的机制.
探索FLC的组合治疗策略.

主要方法:

高通量单核RNA测序来分析FLC时间.
多复合免疫组织化学,实时成像,单细胞测序和空间蛋白质组学.
利用人类瘤切片培养 (TSC) 系统进行FLC TIME的实验调制.

主要成果:

在FLC TIME中鉴定出失调的树皮免疫信号,包括CXCL12+肌纤维细胞和CXCR4+淋巴细胞相互作用.
抑制CXCR4将T细胞调动到瘤中;PD-1阻断激活了T细胞效应器功能.
结合CXCR4和PD-1阻断在人类TSC模型中显著增加瘤细胞死亡.

结论:

在FLC中的免疫抵抗涉及T细胞排斥和枯竭.
结合CXCR4和PD-1封锁可以合作克服这些抵抗机制.
人类TSC系统适用于罕见癌症研究;研究结果支持FLC的组合免疫疗法设计.

关键词:

在CXCL12中,CXCL12是最重要的.组合免疫疗法组合免疫疗法纤维状癌细胞瘤瘤免疫微环境

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...